Sources · 208 listed
Sources behind the answers.
Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.
Showing 141–160 of 208 sources
Source types explained
Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis
Melanotan II: a possible cause of renal infarction — review of the literature and case report
Melanotan tanning injection: a rare cause of priapism
Melanoma associated with the use of melanotan-II
Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?
Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review
Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the internet
SCENESSE (afamelanotide) prescribing information
VYLEESI (bremelanotide) prescribing information
Scenesse European public assessment report
Fake tan and melanotan injections
Individual issued 27 infringement notices for allegedly supplying melanotan II
WADA Prohibited List
2026 WADA Prohibited List summary
FDA evaluation of Semax-related bulk drug substances
FDA substance record for Semax free base
The efficacy of Semax in the treatment of patients at different stages of ischemic stroke
Effectiveness of Semax in acute period of hemispheric ischemic stroke
About this list
How this list works
This list includes sources used in the peptide reviews. Each source appears once, followed by the reviews that use it. Guide citations stay on their guide pages. A source here may support some claims, not every claim, about a peptide.